Literature DB >> 20739736

Ascertainment and verification of diabetes in the EPIC-NL study.

I Sluijs1, D L van der A, J W J Beulens, A M W Spijkerman, M M Ros, D E Grobbee, Y T van der Schouw.   

Abstract

BACKGROUND: The objectives of this study were to describe in detail the ascertainment and verification of prevalent and incident diabetes in the Dutch contributor to the European Prospective Investigation into Cancer and Nutrition (EPIC-NL cohort) and to examine to what extent ascertained diabetes agreed with general practitioner (GP) and pharmacy records.
METHODS: In total, 40,011 adults, aged 21 to 70 years at baseline, were included. Diabetes was ascertained via self-report, linkage to registers of hospital discharge diagnoses (HDD) and a urinary glucose strip test. Ascertained diabetes cases were verified against GP or pharmacist information using mailed questionnaires.
RESULTS: At baseline, 795 (2.0%) diabetes cases were ascertained, and 1494 (3.7%) during a mean follow-up of ten years. The majority was ascertained via self-report only (56.7%), or self-report in combination with HDD (18.0%). After verification of ascertained diabetes cases, 1532 (66.9%) [corrected] were defined as having diabetes , 495 (21.6%) as non-diabetic individuals, and 262 (11.5%) as uncertain. Of the 1538 cases ascertained by self-report, 1350 (positive predictive value: 87.8%) were confirmed by GP or pharmacist. Cases ascertained via self-report in combination with HDD were most often confirmed (334 (positive predictive value: 96.0%)).
CONCLUSIONS: Two out of three ascertained diabetes cases were confirmed to have been diagnosed with diabetes by their GP or pharmacist. Diabetes cases ascertained via self-report in combination with HDD had the highest confirmation.

Entities:  

Mesh:

Year:  2010        PMID: 20739736

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  24 in total

1.  Dietary patterns and the risk of type 2 diabetes in overweight and obese individuals.

Authors:  Florianne Bauer; Joline W J Beulens; Daphne L van der A; Cisca Wijmenga; Diederick E Grobbee; Annemieke M W Spijkerman; Yvonne T van der Schouw; N Charlotte Onland-Moret
Journal:  Eur J Nutr       Date:  2012-07-28       Impact factor: 5.614

2.  Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus.

Authors:  S van Dieren; U Nöthlings; Y T van der Schouw; A M W Spijkerman; G E H M Rutten; D L van der A; D Sluik; C Weikert; H G Joost; H Boeing; J W J Beulens
Journal:  Diabetologia       Date:  2010-10-20       Impact factor: 10.122

3.  Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.

Authors:  Ali Abbasi; Linda M Peelen; Eva Corpeleijn; Yvonne T van der Schouw; Ronald P Stolk; Annemieke M W Spijkerman; Daphne L van der A; Karel G M Moons; Gerjan Navis; Stephan J L Bakker; Joline W J Beulens
Journal:  BMJ       Date:  2012-09-18

4.  Famine exposure in the young and the risk of type 2 diabetes in adulthood.

Authors:  Annet F M van Abeelen; Sjoerd G Elias; Patrick M M Bossuyt; Diederick E Grobbee; Yvonne T van der Schouw; Tessa J Roseboom; Cuno S P M Uiterwaal
Journal:  Diabetes       Date:  2012-05-29       Impact factor: 9.461

5.  Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease.

Authors:  Cécile M Povel; Joline W Beulens; Yvonne T van der Schouw; Martijn E T Dollé; Annemieke M W Spijkerman; W M Monique Verschuren; Edith J M Feskens; Jolanda M A Boer
Journal:  Diabetes Care       Date:  2012-08-29       Impact factor: 19.112

6.  Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp.

Authors:  Jana V van Vliet-Ostaptchouk; Timon W van Haeften; Gijs W D Landman; Erwin Reiling; Nanne Kleefstra; Henk J G Bilo; Olaf H Klungel; Anthonius de Boer; Cleo C van Diemen; Cisca Wijmenga; H Marike Boezen; Jacqueline M Dekker; Esther van 't Riet; Giel Nijpels; Laura M C Welschen; Hata Zavrelova; Elinda J Bruin; Clara C Elbers; Florianne Bauer; N Charlotte Onland-Moret; Yvonne T van der Schouw; Diederick E Grobbee; Annemieke M W Spijkerman; Daphne L van der A; Annemarie M Simonis-Bik; Elisabeth M W Eekhoff; Michaela Diamant; Mark H H Kramer; Dorret I Boomsma; Eco J de Geus; Gonneke Willemsen; P Eline Slagboom; Marten H Hofker; Leen M 't Hart
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

7.  Low fertility and the risk of type 2 diabetes in women.

Authors:  Clara C Elbers; N Charlotte Onland-Moret; Marinus J C Eijkemans; Cisca Wijmenga; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  Hum Reprod       Date:  2011-10-16       Impact factor: 6.918

8.  The impact of a healthy lifestyle on Disability-Adjusted Life Years: a prospective cohort study.

Authors:  Anne M May; Ellen A Struijk; Heidi P Fransen; N Charlotte Onland-Moret; G Ardine de Wit; Jolanda M A Boer; Yvonne T van der Schouw; Jeljer Hoekstra; H Bas Bueno-de-Mesquita; Petra H M Peeters; Joline W J Beulens
Journal:  BMC Med       Date:  2015-02-27       Impact factor: 8.775

9.  Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.

Authors:  Ali Abbasi; Stephan J L Bakker; Eva Corpeleijn; Daphne L van der A; Ron T Gansevoort; Rijk O B Gans; Linda M Peelen; Yvonne T van der Schouw; Ronald P Stolk; Gerjan Navis; Annemieke M W Spijkerman; Joline W J Beulens
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

10.  Osteocalcin Is Not Associated with the Risk of Type 2 Diabetes: Findings from the EPIC-NL Study.

Authors:  Sabine R Zwakenberg; Caren M Gundberg; Annemieke M W Spijkerman; Daphne L van der A; Yvonne T van der Schouw; Joline W J Beulens
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.